| Antonia E Williams, DO | |
|
832 Princeton Ave Sw, Birmingham, AL 35211-1320 | |
| (205) 206-8477 | |
| (205) 397-0986 |
| Full Name | Antonia E Williams |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 832 Princeton Ave Sw, Birmingham, Alabama |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376574673 | NPI | - | NPPES |
| 009937043 | Medicaid | AL | |
| 193783 | Medicaid | AL | |
| 511-85910 | Other | AL | BCBS OF ALABAMA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | DO874 (Alabama) | Primary |
| Entity Name | Obstetrics & Gynecology Of Dothan Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114021409 PECOS PAC ID: 9436051877 Enrollment ID: O20040124000415 |
News Archive
Abide Therapeutics, a developer of innovative pharmaceuticals, announced today initiation of enrollment and dosing of the first subject in a Phase 1a clinical study of ABX-1431, a first-in-class, investigational endocannabinoid system modulator.
A selection of health policy stories from Kansas, Connecticut, Oregon, the District of Columbia, Texas, Florida, Minnesota and California.
Boehringer Ingelheim announced today that the European Committee for Medicinal Products for Human Use (CHMP) adopted a Positive Opinion for the approval of TWYNSTA®. It will be indicated in adults whose blood pressure is not adequately controlled on amlodipine and is also indicated as replacement therapy in adult patients receiving telmisartan and amlodipine from separate tablets can instead receive tablets of TWYNSTA containing the same component doses.
Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced a new contractual agreement with Generation Health, Inc. (GH). This agreement makes Clarient a preferred genetic testing lab for GH, thereby ensuring reimbursement of diagnostic tests done for GH's nationwide network of payor clients and expanding Clarient's potential market. GH is a genetic benefit management company partially-owned by CVS Caremark, the nation's largest pharmacy healthcare provider.
› Verified 2 days ago
| Entity Name | Vincentian Physician Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851698310 PECOS PAC ID: 1557548161 Enrollment ID: O20110608000452 |
News Archive
Abide Therapeutics, a developer of innovative pharmaceuticals, announced today initiation of enrollment and dosing of the first subject in a Phase 1a clinical study of ABX-1431, a first-in-class, investigational endocannabinoid system modulator.
A selection of health policy stories from Kansas, Connecticut, Oregon, the District of Columbia, Texas, Florida, Minnesota and California.
Boehringer Ingelheim announced today that the European Committee for Medicinal Products for Human Use (CHMP) adopted a Positive Opinion for the approval of TWYNSTA®. It will be indicated in adults whose blood pressure is not adequately controlled on amlodipine and is also indicated as replacement therapy in adult patients receiving telmisartan and amlodipine from separate tablets can instead receive tablets of TWYNSTA containing the same component doses.
Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced a new contractual agreement with Generation Health, Inc. (GH). This agreement makes Clarient a preferred genetic testing lab for GH, thereby ensuring reimbursement of diagnostic tests done for GH's nationwide network of payor clients and expanding Clarient's potential market. GH is a genetic benefit management company partially-owned by CVS Caremark, the nation's largest pharmacy healthcare provider.
› Verified 2 days ago
| Entity Name | Cahaba Medical Care Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316201809 PECOS PAC ID: 1355597923 Enrollment ID: O20121120000238 |
News Archive
Abide Therapeutics, a developer of innovative pharmaceuticals, announced today initiation of enrollment and dosing of the first subject in a Phase 1a clinical study of ABX-1431, a first-in-class, investigational endocannabinoid system modulator.
A selection of health policy stories from Kansas, Connecticut, Oregon, the District of Columbia, Texas, Florida, Minnesota and California.
Boehringer Ingelheim announced today that the European Committee for Medicinal Products for Human Use (CHMP) adopted a Positive Opinion for the approval of TWYNSTA®. It will be indicated in adults whose blood pressure is not adequately controlled on amlodipine and is also indicated as replacement therapy in adult patients receiving telmisartan and amlodipine from separate tablets can instead receive tablets of TWYNSTA containing the same component doses.
Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced a new contractual agreement with Generation Health, Inc. (GH). This agreement makes Clarient a preferred genetic testing lab for GH, thereby ensuring reimbursement of diagnostic tests done for GH's nationwide network of payor clients and expanding Clarient's potential market. GH is a genetic benefit management company partially-owned by CVS Caremark, the nation's largest pharmacy healthcare provider.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Antonia E Williams, DO Po Box 12366, Birmingham, AL 35202-2366 Ph: (205) 780-7101 | Antonia E Williams, DO 832 Princeton Ave Sw, Birmingham, AL 35211-1320 Ph: (205) 206-8477 |
News Archive
Abide Therapeutics, a developer of innovative pharmaceuticals, announced today initiation of enrollment and dosing of the first subject in a Phase 1a clinical study of ABX-1431, a first-in-class, investigational endocannabinoid system modulator.
A selection of health policy stories from Kansas, Connecticut, Oregon, the District of Columbia, Texas, Florida, Minnesota and California.
Boehringer Ingelheim announced today that the European Committee for Medicinal Products for Human Use (CHMP) adopted a Positive Opinion for the approval of TWYNSTA®. It will be indicated in adults whose blood pressure is not adequately controlled on amlodipine and is also indicated as replacement therapy in adult patients receiving telmisartan and amlodipine from separate tablets can instead receive tablets of TWYNSTA containing the same component doses.
Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced a new contractual agreement with Generation Health, Inc. (GH). This agreement makes Clarient a preferred genetic testing lab for GH, thereby ensuring reimbursement of diagnostic tests done for GH's nationwide network of payor clients and expanding Clarient's potential market. GH is a genetic benefit management company partially-owned by CVS Caremark, the nation's largest pharmacy healthcare provider.
› Verified 2 days ago
James R Dollar, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 48 Medical Park Dr E, Suite 355, Birmingham, AL 35235 Phone: 205-838-3036 Fax: 205-838-5832 | |
Richard Own Burney, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1700 6th Ave S, Birmingham, AL 35233 Phone: 205-996-3130 | |
Sarah Fort Whitehead, M.D. Obstetrics & Gynecology Medicare: May Accept Medicare Assignments Practice Location: 2006 Brookwood Med Ctr Dr Ste 700, Birmingham, AL 35209 Phone: 205-397-1286 Fax: 205-397-1340 | |
Kimberly Hoover, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Percy Charles Hudson, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 806 Saint Vincents Dr, Suite 430, Birmingham, AL 35205 Phone: 205-939-2806 | |
Isuzu Meyer, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Sarah Dunk, Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-4011 |